This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2003 Remove Healthcare Remove Pharmaceutical manufacturing Related Topics
Competition Healthcare Provider Specialization Healthcare Doctors Biopharma Safety Patients Sales FDA More Related Topics >
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines.

Manufacturing 76
Manufacturing Pharmaceutical Healthcare Healthcare 76
article thumbnail

Biosimilars Market Set for Biggest Year Yet in 2023

PM360

APRIL 25, 2023

pharmaceutical industry. Starting with the first adalimumab biosimilar, Amgen’s Amjevita , which launched this January, the healthcare industry is wondering: how broadly will the respective stakeholders see the value and benefits of biosimilar competitors to one of the world’s top selling drugs?

Marketing 97
Marketing Competition Government Manufacturing 97
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024